Timothy C Durazzo1, Stefan Gazdzinski, Ping-Hong Yeh, Dieter J Meyerhoff. 1. Center for Imaging of Neurodegenerative Disease (114M), San Francisco Veterans Administration Medical Center, and Department of Radiology, University of California, 4150 Clement St., San Francisco CA 94121, USA. timothy.durazzo@ucsf.edu
Abstract
AIMS: Resumption of hazardous drinking after treatment is common in alcohol use disorders (AUD). This study examined the ability of multimodality magnetic resonance, neurocognitive, psychiatric and demographic, to predict alcohol consumption after treatment for AUD. METHODS: Seventy treatment-seeking participants completed 1.5T magnetic resonance studies, yielding regional gray matter (GM) and white matter (WM) surrogate markers of neuronal integrity (N-acetylaspartate: NAA) and cell membrane turnover/synthesis (choline: Cho), assessment of major psychiatric disorders and comprehensive neurocognitive assessment after approximately 1 month of abstinence. Participants were followed up 6-12 months after treatment and classified as Abstainers (no alcohol consumption; n=26) and Resumers (any alcohol consumption; n=44). Abstainers and Resumers were contrasted on various outcome measures, and those that significantly differed between groups were entered as factors in a logistical regression model to predict drinking status at follow-up. RESULTS: The following variables were independent predictors of resumption of drinking: temporal GM NAA, frontal WM NAA, frontal GM Cho, processing speed and comorbid unipolar mood disorder. With each standard deviation unit decrease in temporal GM NAA, frontal WM NAA, frontal GM Cho and processing speed, the odds of resumption of drinking were increased 3.1, 3.3, 6.4 and 14.2 times, respectively. Diagnosis of a unipolar mood disorder was associated with 14.5-fold increased odds of resumed drinking. CONCLUSIONS: The findings suggest that Resumers, relative to Abstainers, demonstrated greater abnormalities in anterior frontal-subcortical circuits involved in mood and behavioral regulation, and development and maintenance of alcohol use disorders, The magnetic resonance-derived variables used in this study may provide additional information regarding the prediction and neurobiological correlates of resumption of hazardous drinking.
AIMS: Resumption of hazardous drinking after treatment is common in alcohol use disorders (AUD). This study examined the ability of multimodality magnetic resonance, neurocognitive, psychiatric and demographic, to predict alcohol consumption after treatment for AUD. METHODS: Seventy treatment-seeking participants completed 1.5T magnetic resonance studies, yielding regional gray matter (GM) and white matter (WM) surrogate markers of neuronal integrity (N-acetylaspartate: NAA) and cell membrane turnover/synthesis (choline: Cho), assessment of major psychiatric disorders and comprehensive neurocognitive assessment after approximately 1 month of abstinence. Participants were followed up 6-12 months after treatment and classified as Abstainers (no alcohol consumption; n=26) and Resumers (any alcohol consumption; n=44). Abstainers and Resumers were contrasted on various outcome measures, and those that significantly differed between groups were entered as factors in a logistical regression model to predict drinking status at follow-up. RESULTS: The following variables were independent predictors of resumption of drinking: temporal GM NAA, frontal WM NAA, frontal GM Cho, processing speed and comorbid unipolar mood disorder. With each standard deviation unit decrease in temporal GM NAA, frontal WM NAA, frontal GM Cho and processing speed, the odds of resumption of drinking were increased 3.1, 3.3, 6.4 and 14.2 times, respectively. Diagnosis of a unipolar mood disorder was associated with 14.5-fold increased odds of resumed drinking. CONCLUSIONS: The findings suggest that Resumers, relative to Abstainers, demonstrated greater abnormalities in anterior frontal-subcortical circuits involved in mood and behavioral regulation, and development and maintenance of alcohol use disorders, The magnetic resonance-derived variables used in this study may provide additional information regarding the prediction and neurobiological correlates of resumption of hazardous drinking.
Authors: D J Meyerhoff; R Blumenfeld; D Truran; J Lindgren; D Flenniken; V Cardenas; L L Chao; J Rothlind; C Studholme; M W Weiner Journal: Alcohol Clin Exp Res Date: 2004-04 Impact factor: 3.455
Authors: D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: Andreas Heinz; Jana Wrase; Thorsten Kahnt; Anne Beck; Zohra Bromand; Sabine M Grüsser; Thorsten Kienast; Michael N Smolka; Herta Flor; Karl Mann Journal: Alcohol Clin Exp Res Date: 2007-05-04 Impact factor: 3.455
Authors: Brett Froeliger; Rachel V Kozink; Jed E Rose; Frederique M Behm; Alfred N Salley; F Joseph McClernon Journal: Psychopharmacology (Berl) Date: 2010-04-28 Impact factor: 4.530
Authors: Samet Kose; Joel L Steinberg; F Gerard Moeller; Joshua L Gowin; Edward Zuniga; Zahra N Kamdar; Joy M Schmitz; Scott D Lane Journal: Behav Neurosci Date: 2015-02-09 Impact factor: 1.912
Authors: Valerie A Cardenas; Timothy C Durazzo; Stefan Gazdzinski; Anderson Mon; Colin Studholme; Dieter J Meyerhoff Journal: Biol Psychiatry Date: 2011-05-20 Impact factor: 13.382
Authors: Timothy C Durazzo; David L Pennington; Thomas P Schmidt; Dieter J Meyerhoff Journal: Alcohol Clin Exp Res Date: 2014-10-21 Impact factor: 3.455
Authors: T Schulte; Y-C Jung; E V Sullivan; A Pfefferbaum; M Serventi; E M Müller-Oehring Journal: Brain Imaging Behav Date: 2017-12 Impact factor: 3.978
Authors: Yukai Zou; Donna E Murray; Timothy C Durazzo; Thomas P Schmidt; Troy A Murray; Dieter J Meyerhoff Journal: Psychiatry Res Neuroimaging Date: 2018-09-18 Impact factor: 2.376
Authors: Emil F Coccaro; Sarah K Keedy; Stephanie M Gorka; Andrea C King; Jennifer R Fanning; Royce J Lee; K Luan Phan Journal: Psychiatry Res Neuroimaging Date: 2016-09-09 Impact factor: 2.376